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Abstract
Our previous studies have demonstrated that the effects of the immune cytokine interferon-c (IFN-c) in immune-mediated
demyelinating diseases are mediated, at least in part, by the unfolded protein response (UPR) in oligodendrocytes. Data
indicate that some biological effects of IFN-c are elicited through activation of the transcription factor nuclear factor-kB (NF-
kB). Interestingly, it has been shown that activation of the pancreatic endoplasmic reticulum kinase (PERK) branch of the
UPR triggers NF-kB activation. In this study, we showed that IFN-c-induced NF-kB activation was associated with activation
of PERK signaling in the oligodendroglial cell line Oli-neu. We further demonstrated that blockage of PERK signaling
diminished IFN-c-induced NF-kB activation in Oli-neu cells. Importantly, we showed that NF-kB activation in
oligodendrocytes correlated with activation of PERK signaling in transgenic mice that ectopically express IFN-c in the
central nervous system (CNS), and that enhancing IFN-c-induced activation of PERK signaling further increased NF-kB
activation in oligodendrocytes. Additionally, we showed that suppression of the NF-kB pathway rendered Oli-neu cells
susceptible to the cytotoxicity of IFN-c, reactive oxygen species, and reactive nitrogen species. Our results indicate that the
UPR is involved in IFN-c-induced NF-kB activation in oligodendrocytes and suggest that NF-kB activation by IFN-c
represents one mechanism by which IFN-c exerts its effects on oligodendrocytes in immune-mediated demyelinating
diseases.
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Introduction
The immune cytokine interferon-c (IFN-c) plays a critical role
in immune-mediated demyelinating diseases multiple sclerosis
(MS) and experimental autoimmune encephalomyelitis (EAE)
[1,2]. Recent studies suggest that the actions of IFN-c in MS and
EAE are mediated, at least in part, by its effects on oligodendro-
cytes [3,4,5]. Nevertheless, the molecular mechanisms by which
IFN-c influences the function and viability of oligodendrocytes
remain elusive. The transcription factor nuclear factor-kB (NF-kB)
is a hetero- or homodimer of the Rel family of proteins, including
p65, c-Rel, RelB, p50, and p52 [6,7]. In the quiescent state, NF-
kB remains inactive in the cytoplasm through interaction with
inhibitory proteins, NF-kB inhibitors (IkBs). Activation of NF-kB
involves the cytoplasmic degradation of IkBs, allowing the
translocation of NF-kB into the nucleus where the dimer binds
to the kB consensus DNA sequence and regulates transcription of
genes that are essential for innate and adaptive immunity and for
regulation of cell apoptosis and survival. There is evidence that the
NF-kB pathway is involved in the pathogenesis of MS and EAE
[7,8,9]. Activation of the NF-kB pathway has been observed in
oligodendrocytes in these diseases [8]. Importantly, several lines of
evidence have suggested that the NF-kB pathway is involved in
mediating the actions of IFN-c [10,11]. Therefore, it is interesting
to determine the involvement of the NF-kB pathway in the effects
of IFN-c on oligodendrocytes.
While evidence is accumulating that IFN-c activates the NF-kB
pathway [11,12], its underlying mechanisms remain elusive.
Endoplasmic reticulum (ER) stress, initiated by the accumulation
of unfolded or misfolded proteins in the ER lumen, activates an
adaptive program known as the unfolded protein response (UPR)
[13,14]. In eukaryotic cells, monitoring of the ER lumen and
signaling through the canonical branches of the UPR are mediated
by three ER-resident transmembrane proteins, pancreatic ER
kinase (PERK), inositol requiring enzyme 1 (IRE1), and activating
transcription factor 6 (ATF6). PERK activation inhibits global
protein translation, but stimulates the expression of certain stress-
induced cytoprotective genes by phosphorylating translation
initiation factor 2a (eIF2a). Interestingly, recent discoveries have
demonstrated that activation of PERK signaling triggers NF-kB
activation by repression of IkBa translation [15,16]. Our previous
studies have shown that IFN-c activates PERK signaling in
oligodendrocytes in immune-mediated demyelinating diseases
[3,17,18]. Thus we examine whether IFN-c activates the NF-kB
pathway in oligodendrocytes by a process mediated by the PERK
branch of the UPR.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36408In this study, we show that IFN-c activates both the NF-kB
pathway and the PERK pathway in the oligodendroglial cell line
Oli-neu. We also show that suppression of the NF-kB pathway
makes Oli-neu cells susceptible to the cytotoxicity of IFN-c,
reactive oxygen species, and reactive nitrogen species. Moreover,
we demonstrate that blockage of PERK signaling diminishes NF-
kB activation in Oli-neu cells in response to IFN-c. Importantly,
we provide evidence that PERK signaling contributes to IFN-c-
induced NF-kB activation in oligodendrocytes in transgenic mice
that ectopically express IFN-c in the CNS. Collectively, this study
reveals a novel mechanism responsible for IFN-c-induced NF-kB
activation and suggests that the NF-kB pathway is involved in




The Oli-neu cell line [19] was a generous gift from Dr. Brian
Popko (University of Chicago, Chicago, Illinois), which was
maintained in Dulbecco’s Modified Eagle Medium (DMEM;
Invitrogen, Carlsbad, California) supplemented with 100 mg/ml
apotransferrin (Sigma-Aldrich, St. Louis, Missouri), 30 nM
sodium selenite (Sigma-Aldrich), 5 mg/ml insulin (Sigma-Al-
drich), 100 mM putrescine (Sigma-Aldrich), 20 nM progesterone
(Sigma-Aldrich), 2 mM L-glutamine (Invitrogen), 25 mM
HEPES (Invitrogen), 10 ng/ml Biotin (Sigma-Aldrich), 1 mM
sodium Pyruvate (Invitrogen), 1% penicillin/streptomycin (In-
vitrogen), and 1% horse serum (Invitrogen). To suppress the
activity of the NF-kB pathway, Oli-neu cells were transfected
with a mammalian expression plasmid pcDNA3.1-IkBaDN that
contains the hygromycin resistance gene using Lipofectamine
2000 transfection reagent (Invitrogen) according to the manu-
facturer’s instructions. The IkBaDN cDNA clone was a
generous gift from Dr. Dean W. Ballard (Vanderbilt University,
Nashville, Tennessee). The stably transfected cells were selected
with 200 mg/ml hygromycin. To block the activity of the PERK
pathway, Oli-neu cells were transfected with a mammalian
expression plasmid pBabe-PERKDC that contains the puromy-
cin resistance gene [20] using Lipofectamine 2000 transfection
reagent (Invitrogen) according to the manufacturer’s instruc-
tions. The stably transfected cells were selected with 0.5 mg/ml
puromycin.
MTT Assay, BrdU Cell Proliferation Assay, and Caspase-3
Activity Assay
Oli-neu cells were plated 1610
4 per well in 96-well microtiter
plates. After 24 hrs, the cells were treated with either IFN-c
(EMD Biosciences, San Diego, California), hydrogen peroxide
(H2O2; Sigma-Aldrich), or a nitric oxide (NO) donor sodium
nitroprusside (SNP; Sigma-Aldrich) for 24 hrs. Cell viability is
determined by the MTT Assay Kit (Promega, Madison,
Wisconsin) according to the manufacturer’s instructions.
Oli-neu cells were plated at 5610
3 per well in 96-well
microtiter plates. After 24 hrs, IFN-c and Bromodeoxyuridine
(BrdU) labeling solution (Millipore, Billerica, Massachusetts)
were added to the culture media for 24 hrs. Cell proliferation
was determined using the Colorimetric BrdU Cell Proliferation
kit (Millipore) according to the manufacturer’s instructions.
Oli-neu cells were treated with IFN-c for 24 hrs. The activity of
caspase-3 was assessed using the Colorimetric Caspase-3 Assay Kit
(Sigma-Aldrich) according to the manufacturer’s instructions.
NF-kB Electrophoretic Mobility Shift Assay (EMSA)
Oli-neu cells treated with IFN-c (EMD Biosciences) for 16 hrs
were rinsed with ice-cold PBS. Nuclear extract from cells was
prepared using NE-PER Nuclear and Cytoplasmic Extraction Kit
(Pierce, Rockford, Illinois) plus complete Protease Inhibitor
Cocktail Kit (Roche, Indianapolis, Indiana) following the manu-
facturers’ instructions and stored at 280uC until used. The protein
content of each extract was determined by DC Protein Assay (Bio-
Rad Laboratories, Hercules, California). Complementary NF-kB
consensus oligonucleotides 59-AGTTGAGGGGACTTTCC-
CAGGC-39 and 59-GCCTGGGAAAGTCCCCTCAACT-39 (In-
tegrated DNA Technologies, Coralville, Iowa) were end-labeled
with biotin separately using the biotin 39-end DNA Labeling Kit
(Pierce) and then annealed by heating to 95uC for 5 min followed
by slow cooling to room temperature. Probes were stored at –20uC
until used. EMSA was performed with the LightShift Chemilu-
minescent EMSA Kit (Pierce) according to the manufacturer’s
instructions. Briefly, nuclear extract (5 mg) was incubated with
20 fmol biotin 39 end-labeled oligonucleotides. After electropho-
resis, transfer, and cross-linking, the signal was detected by a
peroxidase/luminol system. To confirm the specificity, a 200-fold
excess amount of nonlabeled oligonucleotides (cold probe) was
added. The density of NF-kB DNA-binding complex was
quantified with Kodak 1D Image Analysis software (Kodak,
Hercules, New Haven, Connecticut).
Real-time PCR
RNA was isolated from Oli-neu cells treated with 100 U/ml
IFN-c (EMD Biosciences) for 24 hrs using TRIzol reagent
(Invitrogen) and was treated with DNaseI (Invitrogen) to eliminate
genomic DNA. Reverse transcription was performed using the
iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules,
California). Real-time PCR was performed with iQ Supermix
(Bio-Rad Laboratories) on a real-time PCR detection system
(model iQ; Bio-Rad Laboratories). The following primers and
probes (Integrated DNA Technologies, Inc.) for real-time PCR
were used: glyceraldehyde phosphate dehydrogenase (GAPDH)
sense primer (CTCAACTACATGGTCTACATGTTCCA);
GAPDH antisense primer (CCATTCTCGGCCTTGACTGT);
GAPDH probe (TGACTCCACTCACGGCAAATTCAACG);
CAATT enhancer binding protein homologous protein (CHOP)
sense primer (CCACCACACCTGAAAGCAGAA); CHOP anti-
sense primer (AGGTGCCCCCAATTTCATCT); CHOP probe
(TGAGTCCCTGCCTTTCACCTTGGAGA); binding immuno-
globulin protein (BIP) sense primer (ACTCCGGCGTGAGGTA-
GAAA); BIP antisense primer (AGAGCGGAACAGGTC-
CATGT); BIP probe (TTCTCAGAGACCCTTACTCGGGC-
CAAATT).
Western Blot Analysis
Oli-neu cells treated with IFN-c (EMD Biosciences) were rinsed
with ice-cold PBS and were immediately homogenized in 5
volume of Triton X-100 buffer as previously described [17]. After
incubating on ice for 15 min, the extracts were cleared by
centrifugation at 14,000 rpm twice for 30 min each. The protein
content of each extract was determined by DC Protein Assay (Bio-
Rad Laboratories). The extracts (40 mg) were separated by SDS-
PAGE and were transferred to nitrocellulose. The blots were
incubated with primary antibody (see below), and the signal was
revealed by chemiluminescence after reacting with HRP-conju-
gated second antibody. The following primary antibodies were
used: phosphorylated PERK (p-PERK, 1:1000; Santa Cruz
Biotechnology, Santa Cruz, California); eIF-2a (1:1000; Santa
Cruz Biotechnology); phosphorylated eIF-2a (p-eIF-2a,1:1000;
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(1:4000; Abcam, Cambridge, Massachusetts); IkBa (1:1000; Santa
Cruz Biotechnology), c-Myc [20], and b-actin (1:5000; Sigma-
Aldrich). The density of immunoblotting was quantified with
Kodak 1D Image Analysis software (Kodak, Hercules, New
Haven, Connecticut).
Mice Breeding
Line110 GFAP/tTA mice and line184 TRE/IFN-c mice on the
C57BL/6 background were mated with growth arrest and DNA
damage 34 (GADD34) mutant mice on the C57BL/6 background,
and the resulting progeny were intercrossed to obtain GFAP/tTA;
TRE/IFN-c; GADD34 WT mice and GFAP/tTA; TRE/IFN-c;
GADD34 mutant mice as described in our previous papers [21,22].
To prevent transcriptional activation of the TRE/IFN-c transgene
by tTA, 0.05 mg/ml doxycycline was added to the drinking water
and was provided ad libitum. All animal procedures were conducted
in complete compliance with the National Institutes of Health’s
(NIH) Guide for the Care and Use of Laboratory Animals and
were approved by the Institutional Animal Care and Use
Committee of the University of South Alabama.
Immunohistochemistry (IHC)
Anesthetized mice were perfused through the left cardiac
ventricle with 4% paraformaldehyde in 0.1 M PBS. The brains
were removed, postfixed with paraformaldehyde, cryopreserved
in 30% sucrose, embedded in optimal cutting temperature
compound and frozen on dry ice. Frozen sections were cut in a
cryostat at a thickness of 10 mm and were treated with 220uC
acetone prior to IHC. For IHC, Oli-neu cells treated with IFN-
c were fixed with 4% paraformaldehyde in 0.1 M PBS. Then
the brain sections and the cells were blocked with PBS
containing 10% goat serum and 0.1% Triton X-100 and
incubated overnight with the primary antibody diluted in
blocking solution. Appropriate fluorochrome-labeled secondary
antibodies (Vector Laboratories, Burlingame, California) were
used for detection. An antibody against 29,39-cyclic nucleotide
phosphodiesterase (CNP, 1:200; Santa Cruz Biotechnology) was
used as a marker for myelin and oligodendrocytes. Antibody
against active caspase-3 (1:100; Cell Signaling Technology) was
used to detect activation of caspase-3. Antibodies against p65
(1:400, Santa Cruz Biotechnology) and the active form of p65
(1:50, Millipore, Billerica, Massachusetts) were used to detect
nucleus translocation of p65 and activation of p65, respectively.
Fluorescent stained sections and cells were mounted with
Vectashield mounting medium with DAPI (Vector Laborato-
ries). The stained sections and cells were visualized with the
Nikon A1 confocal microscope or the Nikon Eclipse TE2000U
fluorescence inverted microscope and analyzed as previously
described [17]. Briefly, quantitative p65 nucleus translocation
analyses were performed in 4 separate cell preparations for each
group. Each individual Oli-neu cell was imaged using the Nikon
A1 confocal microscope. We randomly imaged at least 30 cells
in each cell preparation. The results were presented as the
percentage of cells with p65 nucleus translocation.
Statistics
Data are expressed as mean 6 standard deviation. Multiple
comparisons were statistically evaluated by one way ANOVA test
using Sigmastat 3.1 software (Hearne Scientific Software).
Differences were considered statistically significant if p,0.05.
Results
NF-kB Activation Prevented Oli-neu Cells from the
Cytotoxicity of IFN-c
Several lines of evidence have suggested that the effects of IFN-c
on oligodendroglial lineage cells are dependent on the differen-
tiation stages of the cells [5]. It has been shown that IFN-c is not
detrimental to mature oligodendrocytes [3,4,17]. In contrast,
several studies have shown that IFN-c induces myelinating
oligodendrocyte apoptosis [17]. Recent reports have shown that
IFN-c influences the differentiation and proliferation of oligoden-
drocyte precursors, but does not affect the cell viability [23,24].
The oligodendroglial cell line Oli-neu was generated by immor-
talization of mitotic oligodendrocyte precursor cells with retroviral
vectors containing the t-neu oncogene. Oli-neu cells adhere to and
ensheath axons in vitro and in vivo in an oligodendroglial specific
manner [19]. To evaluate the effects of IFN-c on Oli-neu cells, the
cells were treated with 50 U/ml, 100 U/ml, or 150 U/ml IFN-c
for 24 hrs. MTT cell viability and proliferation assay showed that
IFN-c treatment reduced the number of Oli-neu cells in a dose-
dependent manner (Figure 1A). Because MTT assay is not capable
of distinguishing whether the reduction of the number of Oli-neu
cells is due to cell apoptosis or decreased cell proliferation, we
further performed caspase-3 activity assay to determine whether
IFN-c treatment caused cell apoptosis. Interestingly, the activity of
caspase-3 in Oli-neu cells that were treated with 100 U/ml IFN-c
for 24 hrs was comparable to the untreated Oli-neu cells
(Figure 1B). Moreover, active caspase-3 and DAPI double labeling
showed that the treatment with 100 U/ml IFN-c did not
significantly increase the number of apoptotic Oli-neu cells
(Figure 1C, D). Interestingly, BrdU cell proliferation assay showed
that the treatment with 100 U/ml IFN-c significantly inhibited
Oli-neu cell proliferation (Figure 1E). Taken together, these data
indicate that IFN-c suppresses Oli-neu cell proliferation but does
not affect its viability.
It has been shown that the NF-kB pathway is involved in
mediating the actions of IFN-c in the cells [10,11]. Therefore, it is
interesting to determine the potential role of the NF-kB pathway
in the effects of IFN-c on Oli-neu cells. p65 and DAPI double
labeling and confocal imaging analysis showed that p65 remained
in the cytoplasm in the majority of the untreated Oli-neu cells
(Figure 2A). Interestingly, we found that IFN-c treatment induced
translocation of p65 from the cytoplasm to the nucleus in Oli-neu
cells, which indicates NF-kB activation. Quantitative analysis
showed that the percentage of Oli-neu cells with p65 nucleus
translocation was significantly increased after 16 hrs of 100 U/ml
IFN-c treatment (Figure 2B). Moreover, EMSA analysis showed a
significant increase in NF-kB DNA-binding activity in Oli-neu
cells treated with 100 U/ml IFN-c for 16 hrs (Figure 2C, D).
Thus, these data demonstrate that IFN-c activates the NF-kB
pathway in Oli-neu cells.
Next, we determined whether suppression of the NF-kB
pathway rendered Oli-neu cells vulnerable to the cytotoxicity of
IFN-c.I kBaDN, a deletion mutant lacking the N-terminal 36
amino acids of IkBa, is a dominant inhibitor of NF-kB signaling
[25]. To suppress the activity of NF-kB, Oli-neu cells were
transfected with a mammalian expression plasmid pcDNA3.1-
IkBaDN that contains the hygromycin resistance gene. We
obtained several stably transfected cell lines that were resistant
to hygromycin and expressed various levels of IkBaDN (Figure 3A).
Line 1 cells that expressed a moderate level of IkBaDN( I kBaDN
1) and line 4 cells that expressed a high level of IkBaDN( I kBaDN
4) were treated with 100 U/ml IFN-c for 16 hrs. As expected, p65
and DAPI double labeling and confocal imaging analysis showed
IFN-c Induces NF-kB Activation via UPR
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36408that enforced expression of IkBaDN blocked IFN-c-induced p65
nucleus translocation in IkBaDN 1 and 4 cells (Figure 2A, B).
EMSA analysis confirmed that enforced expression of IkBaDN
diminished IFN-c-induced NF-kB activation (Figure 2C, D).
Interestingly, MTT assay showed that IFN-c treatment noticeably
increased the magnitude of the reduction of cell numbers in
IkBaDN 1 and 4 cells compared to control Oli-neu cells
(Figure 1A, the magnitude of the reduction in response to
150 U/ml IFN-c treatment: 32%61.7% in Oli-neu cells vs
43%63.1% in IkBaDN 1 cells and 50%63.4% in IkBaDN4
cells). Caspase-3 activity assay also showed that IFN-c treatment
significantly increased caspase-3 activity in IkBaDN 1 and 4 cells
Figure 1. NF-kB activation promoted Oli-neu cell survival in response to IFN-c.A .The cells were treated with 50 U/ml, 100 U/ml, or 150 U/
ml IFN-c for 24 hrs. MTT assay showed that IFN-c treatment reduced the number of Oli-neu cells in a dose-dependent manner and that enforced
expression of IkBaDN further reduced the cell numbers. B. The cells were treated with 100 U/ml IFN-c for 24 hrs. Caspase-3 activity assay showed
that IFN-c treatment did not alter the activity of caspase-3 in Oli-neu cells. Nevertheless, IFN-c treatment significantly increased the activity of
caspase-3 in IkBaDN 1 and 4 cells. C, D. The cells were treated with 100 U/ml IFN-c for 24 hrs. Active caspase-3 immunostaining showed that IFN-c
treatment did not change the percentage of active caspase-3 positive cells in Oli-neu cells. Nevertheless, IFN-c treatment significantly increased the
percentage of active caspase-3 positive cells in IkBaDN 1 and 4 cells. E. BrdU cell proliferation assay showed that the treatment with 100 U/ml IFN-c
for 24 hrs significantly suppressed Oli-neu cell proliferation. Nevertheless, suppression of the NF-kB pathway did not significantly alter the sensitivity
of Oli-neu cells to the antiproliferative effects of IFN-c. The experiments were repeated at least three times, error bars represent standard deviation,
asterisk p,0.05, scale bar=100 mm.
doi:10.1371/journal.pone.0036408.g001
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showed that IFN-c treatment significantly increased the number of
apoptotic cells in IkBaDN 1 and 4 cells, which were active
caspase-3 positive and had condensed nuclei (Figure 1C, D).
Additionally, we found that both caspase-3 activity and apoptotic
cell numbers were significantly increased in the untreated IkBaDN
1 and 4 cells compared to the untreated control Oli-neu cells
(Figure 1B, D), which likely reflects that NF-kB is involved in
supporting Oli-neu cell survival in the normal condition.
Nevertheless, BrdU cell proliferation assay showed that suppres-
sion of the NF-kB pathway did not significantly alter the sensitivity
of Oli-neu cells to the anti-proliferative effects of IFN-c (Fig. 1E,
the magnitude of the reduction of cell proliferation: 19%64.85%
in Oli-neu cells vs 23%67.8% in IkBaDN 1 cells and 24%67.7%
in IkBaDN 4 cells). Collectively, our data show that NF-kB
activation induced by IFN-c protects Oli-neu cells against the
cytotoxicity of this cytokine.
Figure 2. Enforced expression of IkBaDN blocked IFN-c-induced NF-kB activation. A. The cells were treated with 100 U/ml IFN-c for 16 hrs.
p65 and DAPI double labeling and confocal imaging analysis showed that p65 remained in the cytoplasm in the untreated Oli-neu cells and that IFN-
c treatment induced translocation of p65 from the cytoplasm to the nucleus in Oli-neu cells. Interestingly, IFN-c treatment did not result in p65
nucleus translocation in IkBaDN 1 and 4 cells. B. Quantitative analysis showed that the percentage of Oli-neu cells with p65 nucleus translocation was
significantly increased after 16 hrs of 100 U/ml IFN-c treatment. Nevertheless, enforced expression of IkBaDN blocked IFN-c-induced p65 nucleus
translocation in IkBaDN 1 and 4 cells. C, D. The cells were treated with 100 U/ml IFN-c for 16 hrs. EMSA analysis showed a significant increase in NF-
kB DNA-binding activity in Oli-neu cells treated with IFN-c. Nevertheless, enforced expression of IkBaDN blocked IFN-c-induced increase in NF-kB
DNA-binding activity in IkBaDN 1 and 4 cells. The experiments were repeated at least three times, error bars represent standard deviation, asterisk
p,0.05, scale bar=20 mm.
doi:10.1371/journal.pone.0036408.g002
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susceptible to reactive oxygen species and reactive nitrogen species
[26,27,28]. In accordance with these previous studies, MTT assay
showed that the treatment with H2O2 reduced the number of Oli-
neu cells in a dose-dependent manner (Figure 3B). Similarly, we
found that the treatment with a NO donor SNP reduced the
number of Oli-neu cells in a dose-dependent manner (Figure 3C).
To determine the contribution of the NF-kB pathway in the
response of Oli-neu cells to reactive oxygen species and reactive
nitrogen species, IkBaDN 1 and 4 cells were treated with H2O2
and SNP for 24 hrs, respectively. Interestingly, MTT assay
showed that suppression of the NF-kB pathway made Oli-neu
cells sensitive to the cytotoxicity of H2O2 (Figure 3B, the
magnitude of the reduction of cell viability in response to
Figure 3. Enforced expression of IkBaDN rendered Oli-neu cells sensitive to the cytotoxicity of reactive oxygen species and reactive
nitrogen species. A. Oli-neu cells were transfected with the plasmid pcDNA3.1-IkBaDN. We obtained several stably transfected cell lines that were
resistant to hygromycin and expressed various levels of IkBaDN. IkBaDN 1 cells expressed moderate level of IkBaDN (arrow) and IkBaDN 4 cells
expressed high level of IkBaDN (arrow). B. The cells were treated with 0.2 mM, 0.3 mM, and 0.4 mM H2O2 for 24 hrs. MTT assay showed that the
treatment with H2O2 reduced the number of Oli-neu cells in a dose-dependent manner and that enforced expression of IkBaDN further reduced the
cell numbers. C. The cells were treated with 0.1 mM, 0.2 mM, and 0.3 mM SNP for 24 hrs. MTT assay showed that the treatment with SNP reduced
the number of Oli-neu cells in a dose-dependent manner and that enforced expression of IkBaDN further reduced the cell numbers. The experiments
were repeated at least three times, error bars represent standard deviation, asterisk p,0.05.
doi:10.1371/journal.pone.0036408.g003
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39%62.9% in IkBaDN 1 cells and 46%63.4% in IkBaDN4
cells) and SNP (Figure 3C, the magnitude of the reduction of cell
viability in response to 0.2 mM SNP treatment: 44%62.3% in
Oli-neu cells vs 55%61.3% in IkBaDN 1 cells and 61%61.7% in
IkBaDN 4 cells), respectively. These data further support that the
NF-kB pathway promotes Oli-neu cell survival.
PERK was Required for NF-kB Activation in Response to
IFN-c
During ER stress, PERK activation stimulates the expression of
numerous stress-induced cytoprotective genes by promoting the
translation of the cytosolic transcription factor ATF4 [13,14].
Activation of the PERK-eIF2a pathway also activates the NF-kB
pathway through repression of IkBa translation [15,16]. We have
shown that IFN-c induces ER stress in oligodendroglial lineage
cells using primary cell cultures and animal models [3,17,18].
Interestingly, real-time PCR analysis showed that the levels of the
UPR markers CHOP and BIP were significantly increased in Oli-
neu cells treated with 100 U/ml IFN-c for 24 hrs compared to the
untreated cells (Figure 4A). Moreover, western blot analysis
showed that the levels of p-PERK, p-eIF2a, and ATF4 in Oli-
neu cells treated with 100 U/ml IFN-c for 16 hrs were elevated
compared to the untreated cells (Figure 4B, D, E). Additionally, we
found that IFN-c treatment reduced the level of IkBa in Oli-neu
cells after 16 hrs of treatment (Figure 4B, D). These data
demonstrate that IFN-c activates the PERK pathway in Oli-neu
cells.
We further examined the involvement of PERK signaling in
IFN-c-induced NF-kB activation. PERKDC, a kinase-defective
PERK lacking the C-terminal kinase domain, is a dominant
inhibitor of PERK signaling [20]. Oli-neu cells were transfected
with pBabe-PERKDC vector encoding Myc epitope-tagged
PERKDC [20]. We obtained several stably transfected cell lines
that were resistant to puromycin. Immunoblotting for Myc showed
that stably transfected cell lines expressed various levels of
PERKDC (Figure 4C). Lines 1 and 10 cells (PERKDC 1 and
10) that expressed a high level of PERKDC were treated with
100 U/ml IFN-c for 16 hrs. As expected, western blot analysis
showed that enforced expression of PERKDC blocked IFN-c-
induced eIF2a phosphorylation and ATF4 upregulation in
PERKDC 1 and 10 cells (Figure 4D, E). Western blot analysis
also showed that enforced expression of PERKDC diminished the
reduction of IkBa level in Oli-neu cells in response to IFN-c.
These data demonstrate that enforced expression of PERKDC
blocks activation of PERK signaling in Oli-neu cells in response to
IFN-c. Moreover, p65 and DAPI double labeling and confocal
imaging analysis showed that enforced expression of PERKDC
diminished IFN-c-induced p65 nucleus translocation in PERKDC
1 and 10 cells (Figure 5A, B). Importantly, EMSA analysis showed
that enforced expression of PERKDC blocked NF-kB activation in
PERKDC 1 and 10 cells in response to IFN-c (Figure 5C, D).
Collectively, these data demonstrate that IFN-c activates NF-kBi n
Oli-neu cells through PERK signaling.
It is well documented that PERK signaling is essential for cell
survival during ER stress [13,14]. Moreover, it has been shown
that activation of PERK signaling protects oligodendrocytes
against the cytotoxicity of IFN-c [17,18,21]. To determine
whether enforced expression of PERKDC affects the viability of
Oli-neu cells in response to IFN-c, we performed active caspase-3
and DAPI double labeling. As mentioned above, we found that
IFN-c treatment did not cause Oli-neu cell apoptosis (Figure 1C,
1D, and 6). Nevertheless, active caspase-3 and DAPI double
labeling showed that IFN-c treatment significantly increased the
number of apoptotic cells in PERKDC 1 and 10 cells (Figure 6),
which were active caspase-3 positive and had condensed nuclei.
Taken together, these data demonstrate that blockage of PERK
signaling makes Oli-neu cells susceptible to the cytotoxicity of IFN-
c, which is consistent with our previous studies [17,18,21].
PERK Signaling Contributed to IFN-c-induced NF-kB
Activation in Oligodendrocytes in vivo
We have generated transgenic mice that allow for the
temporally controlled delivery of IFN-c to the CNS using the
tetracycline-controllable system [29]. Using the mouse model, we
have found that the presence of IFN-c in the CNS during
development results in myelinating oligodendrocyte death and
activation of the PERK-eIF2a pathway in the cells [17]. We have
also found that PERK deficiency impairs the activity of the
PERK-eIF2a pathway in myelinating oligodendrocytes in the
CNS of IFN-c-expressing mice and exacerbates IFN-c-induced
oligodendrocyte death [17]. Moreover, our recent study showed
that inactivation of the gene encoding GADD34, a stress-inducible
regulatory subunit of a phosphatase complex that dephosphory-
lates eIF2a, enhanced the activity of the PERK-eIF2a pathway in
myelinating oligodendrocytes in young, developing mice that
express IFN-c in the CNS and promoted the cell survival in
response to IFN-c [21].
To determine whether the PERK-eIF2a pathway was involved
in IFN-c-induced NF-kB activation in oligodendrocytes in
immune-mediated demyelinating diseases, we exploited IFN-c-
expressing transgenic mice and GADD34 mutant mice that have
inactive GADD34 gene. GFAP/tTA mice and TRE/IFN-c mice
were mated with GADD34 mutant mice, and the resulting progeny
were intercrossed to obtain GFAP/tTA; TRE/IFN-c; GADD34 WT
mice as well as GFAP/tTA; TRE/IFN-c; GADD34 mutant mice.
The expression of the IFN-c transgene was repressed in GFAP/
tTA; TRE/IFN-c; GADD34 WT mice and GFAP/tTA; TRE/IFN-c;
GADD34 mutant mice treated with doxycycline solution from
conception (IFNc ¯ GADD34 WT mice and IFNc ¯ GADD34
mutant mice). The levels of IFN-c became detectable around
postnatal day 10 in the CNS of these mice that were released from
doxycycline solution at embryonic day 14 (IFNc+GADD34 WT
mice and IFNc+GADD34 mutant mice). In agreement with a
previous study [30], CNP and active p65 double immunostaining
showed that the immunoreactivity of active p65 was undetectable
in oligodendrocytes in the corpus callosum in 21-day-old control
IFNc ¯ GADD34 WT mice and IFNc ¯ GADD34 mutant mice
(Figure 7). Importantly, we found that immunoreactivity of active
p65 became detectable in a number of oligodendrocytes in the
corpus callosum in 21-day-old IFNc+GADD34 WT mice, and
that the number of active p65 positive oligodendrocytes was
further increased in the corpus callosum of IFNc+GADD34
mutant mice. These results likely reflect that enhanced activation
of the PERK-eIF2a pathway via GADD34 inactivation leads to
elevated activation of the NF-kB pathway in oligodendrocytes in
IFN-c-expressing transgenic mice. Our data suggest that IFN-c
can activate NF-kB in oligodendrocytes in immune-mediated
demyelinating diseases, and the PERK-eIF2a pathway contributes
to IFN-c-induced NF-kB activation. Additionally, these findings
indicate that the beneficial effects of PERK signaling on
oligodendrocytes in IFN-c-expressing mice are associated with
NF-kB activation.
Discussion
IFN-c is considered to be a key cytokine involved in the
pathogenesis of immune-mediated demyelinating diseases [2,5].
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36408Figure 4. Enforced expression of PERKDC diminished IFN-c-induced activation of PERK signaling. A. Oli-neu cells were treated with
100 U/ml IFN-c for 24 hrs. Real-time PCR analysis showed that IFN-c treatment significantly increased the expression of CHOP and BIP in the cells. B.
The cells were treated with 100 U/ml IFN-c for 8 hrs, 16 hrs, or 24 hrs. Western blot analysis showed that the levels of p-PERK, p-eIF2a, and ATF4 in
Oli-neu cells treated with 100 U/ml IFN-c for 16 hrs were elevated compared to the untreated cells. Moreover, IFN-c reduced the level of IkBa in Oli-
neu cells after 16 hrs of treatment. C. Oli-neu cells were transfected with pBabe-PERKDC vector encoding Myc epitope-tagged PERKDC.
Immunoblotting for Myc showed that stably transfected cell lines expressed various levels of PERKDC. PERKDC 1 and 10 cells expressed high level of
PERKDC. D. The cells were treated with 100 U/ml IFN-c for 16 hrs. Western blot analysis showed that enforced expression of PERKDC blocked IFN-c-
induced eIF2a phosphorylation and ATF4 upregulation in PERKDC 1 and 10 cells. Western blot analysis also showed that enforced expression of
PERKDC diminished IFN-c-induced reduction of IkBa level in PERKDC 1 and 10 cells. E. Densitometry analysis of western blot results showed that IFN-
c treatment significantly increased the level of p-eIF2a in Oli-neu cells, but did not affect p-eIF2a level in PERKDC 1 and 10 cells. The experiments
were repeated at least three times, error bars represent standard deviation, asterisk p,0.05.
doi:10.1371/journal.pone.0036408.g004
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36408Several lines of evidence have suggested that the NF-kB pathway
plays an important role in immune-mediated demyelinating
diseases [7,8,9,31,32]. Interestingly, recent studies have shown
that some biological effects of IFN-c are elicited through activation
of the NF-kB pathway [11,12]. Our previous studies have shown
that the effects of IFN-c on oligodendrocytes in immune-mediated
demyelinating diseases are mediated, at least in part, by the UPR
[3,17,18]. Moreover, it has been shown that activation of the
PERK branch of the UPR activates the NF-kB pathway in ER-
stressed cells [15,16]. Therefore, in this study, we determined the
potential role of the NF-kB pathway in the effects of IFN-c on
oligodendrocytes and the molecular mechanism responsible for
IFN-c-induced NF-kB activation. First, using oligodendroglial cell
line Oli-neu, we found that IFN-c was capable of acting on the
cells to activate the NF-kB pathway and that NF-kB activation was
essential to protect Oli-neu cells against IFN-c-induced apoptosis.
Second, we showed that IFN-c-induced NF-kB activation
correlated with activation of PERK signaling and was abrogated
in Oli-neu cells with enforced expression of PERKDC, a dominant
inhibitor of PERK signaling. Third, we showed that IFN-c
induced NF-kB activation in oligodendrocytes in transgenic mice
that ectopically express IFN-c in the CNS. Finally, we found that
Figure 5. Enforced expression of PERKDC impaired IFN-c-induced NF-kB activation. A, B. The cells were treated with 100 U/ml IFN-c for
16 hrs. p65 and DAPI double labeling and confocal imaging analysis showed that enforced expression of PERKDC diminished IFN-c-induced p65
nucleus translocation in PERKDC 1 and 10 cells. C, D. The cells were treated with 100 U/ml IFN-c for 16 hrs. EMSA analysis showed that enforced
expression of PERKDC blocked IFN-c-induced increase in NF-kB DNA-binding activity in PERKDC 1 and 10 cells. The experiments were repeated at
least three times, error bars represent standard deviation, asterisk p,0.05, scale bar=20 mm.
doi:10.1371/journal.pone.0036408.g005
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36408inactivation of the GADD34 gene enhanced IFN-c-induced
activation of the PERK-eIF2a pathway in oligodendrocytes in
IFN-c-expressing transgenic mice, resulting in increased NF-kB
activation. Collectively, these data provide compelling evidence
that the UPR induced by IFN-c represents one mechanism by
which IFN-c triggers NF-kB activation in oligodendrocytes in
immune-mediated demyelinating diseases.
It remains unclear how IFN-c causes ER stress in oligodendro-
cytes. IFN-c enhances the production of hundreds of distinct
proteins in cells, including oligodendrocytes [33,34]. It is possible
that enhanced production of proteins leads to an overload of the
capacity of the ER, resulting in ER stress. Many aspects of IFN-c
biology are exerted through the Janus kinases (JAKs) - signal
transducer and activator of transcription 1 (STAT1) pathway
[12,35]. Recently, we have demonstrated that the presence of
IFN-c in the CNS activates the UPR in oligodendrocytes through
the JAK-STAT1 pathway [36]. Activation of the PERK branch of
the UPR adapts cells to the ER-stressed conditions by inhibiting
global protein biosynthesis [13,14]. Interestingly, it has been
demonstrated that inhibition of IkBa biosynthesis by the PERK-
Figure 6. Enforced expression of PERKDC made Oli-neu cells susceptible to the cytotoxicity of IFN-c.A ,B .The cells were treated with
100 U/ml IFN-c for 24 hrs. Active caspase-3 and DAPI double labeling showed that IFN-c treatment did not cause Oli-neu cell apoptosis, but
significantly increased the number of apoptotic cells in PERKDC 1 and 10 cells. The experiments were repeated at least three times, error bars
represent standard deviation, asterisk p,0.05, scale bar=100 mm.
doi:10.1371/journal.pone.0036408.g006
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36408eIF2a pathway leads to NF-kB activation [15,16]. Herein, we
showed that IFN-c-induced NF-kB activation in Oli-neu cells
correlated with the reduction of IkBa level. Importantly, we
showed that enforced expression of PERKDC diminished IFN-c-
induced reduction of IkBa level and NF-kB activation in Oli-neu
cells. Taken together, our findings suggest that IFN-c induces NF-
kB activation by activating PERK signaling through the JAK-
STAT1 pathway. On the other hand, recent studies suggest that
multiple mechanisms are involved in IFN-c-induced NF-kB
activation. A study showed that IFN-c activated the NF-kB
pathway through a STAT1-independent pathway [37]. A recent
report showed that IFN-c activated IkB kinase b (IKK-b)-
dependent NF-kB signaling through the JAK-STAT1 pathway
[11]. Collectively, these data raise the possibility that the
mechanisms responsible for IFN-c-induced NF-kB activation are
determined by the cell types. Additionally, this study does not rule
Figure 7. GADD34 inactivation increased IFN-c-induced NF-kB activation in oligodendrocytes in IFN-c-expressing transgenic mice.
A, B. CNP and active p65 double immunostaining showed that the immunoreactivity of active p65 was undetectable in oligodendrocytes in the
corpus callosum in control IFNc ¯ GADD34 WT mice and IFNc ¯ GADD34 mutant mice. The immunoreactivity of active p65 became detectable in a
number of oligodendrocytes in the corpus callosum of IFNc+GADD34 WT mice, and the number of active p65 positive oligodendrocytes was further
increased in the corpus callosum of IFNc+GADD34 mutant mice. The experiments were repeated at least three times, error bars represent standard
deviation, asterisk p,0.05, scale bar=20 mm.
doi:10.1371/journal.pone.0036408.g007
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e36408out the possibility that other mechanisms are involved in IFN-c-
induced NF-kB activation in oligodendrocytes in immune-
mediated demyelinating diseases. We have demonstrated that
the presence of IFN-c in the CNS increases the expression of
tumor necrosis factor-a (TNF-a), a well characterized NF-kB
inducer [21,36]. An alternative, but not mutually exclusive,
possibility is that IFN-c activates NF-kB in oligodendrocytes in
immune-mediated demyelinating diseases through the induction of
TNF-a.
Oligodendrocytes are considered to be the target of immune
attacks in immune-mediated demyelinating diseases [38]. Recent
studies suggest that oligodendrocyte death contributes significantly
to the development of immune-mediated demyelinating diseases
[39,40]. Moreover, oligodendrocyte regeneration and subsequent
remyelination are thought to be necessary to restore neurological
function in MS patients and EAE animals [41]. Several lines of
evidence have suggested that the effects of IFN-c on oligodendro-
cytes are dependent on the differentiation stages of the cells
[5,23,24]. Our previous study has shown that IFN-c protects
mature oligodendrocytes in adult animals against immune attacks
in EAE mice [3]. Moreover, we have demonstrated that the
beneficial effects of IFN-c on mature oligodendrocytes are
associated with modest ER stress and that PERK deficiency
diminishes the protective effects [3]. In contrast, we have shown
that IFN-c causes myelinating oligodendrocyte death in young,
developing mice and remyelinating oligodendrocyte death in EAE
demyelinated lesions [17,18,21]. We have also demonstrated that
the detrimental effects of IFN-c on (re)myelinating oligodendro-
cytes are associated with severe ER stress and that PERK
deficiency makes (re)myelinating oligodendrocytes more sensitive
to IFN-c [17,18]. On the other hand, it has been shown that IFN-
c influences the proliferation of oligodendrocyte precursors, but
does not affect the viability of oligodendrocyte precursors [23,24].
In agreement with these studies, we showed here that IFN-c
suppressed the proliferation of Oli-neu cells, an oligodendrocyte
precursor cell line, but had no effect on the cell viability.
Interestingly, we found that IFN-c induced modest ER stress in
Oli-neu cells and that blockage of PERK signaling resulted in the
death of Oli-neu cells in response to IFN-c. Collectively, these data
indicate that activation of PERK signaling induced by IFN-c is
exclusively beneficial to oligodendrocytes in immune-mediated
demyelinating diseases, in spite of double-edged sword effects of
IFN-c on the cells.
It is generally believed that inflammatory mediators, including
immune cytokines, reactive oxygen species, and reactive nitrogen
species, contribute to oligodendrocyte death in immune-mediated
demyelinating diseases [27,38]. Several studies have shown that
NF-kB activation promotes immortalized oligodendrocyte survival
in response to inflammatory mediators [26,42,43]. We showed
here that NF-kB not only supported Oli-neu cell survival under
the normal condition but also promoted Oli-neu cell survival in
response to IFN-c, reactive oxygen species, and reactive nitrogen
species. Our data provide additional evidence that NF-kB
activation is beneficial to oligodendrocyte survival in immune-
mediated demyelinating diseases. We also showed that IFN-c
induced NF-kB activation in Oli-neu cells through PERK
signaling. On the other hand, our previous study has shown that
GADD34 inactivation enhances the activity of PERK signaling in
myelinating oligodendrocytes and promotes the cell survival in
young, developing mice that express IFN-c in the CNS [21].
Importantly, in this study, we showed that the GADD34
inactivation enhanced IFN-c-induced NF-kB activation in oligo-
dendrocytes in the mice. These findings indicate that NF-kB
activation contributes to cytoprotective effects of PERK signaling
on oligodendrocytes in IFN-c-expressing mice. Additionally, it has
been demonstrated that both the PERK pathway and the NF-kB
pathway are activated in oligodendrocytes in immune-mediated
demyelinating diseases [3,8,44]. Taken together, these data raise
the possibility that the cytoprotective effects of IFN-c-induced
PERK activation on oligodendrocytes in immune-mediated
demyelinating diseases are mediated by the NF-kB pathway. In
contrast, a recent study showed that oligodendrocyte-restricted
deletion of IKKb had no noticeable effects on oligodendrocyte
viability in mice with EAE [30]. Both IKKb-dependent and
IKKb-independent pathways are involved in NF-kB activation in
cells [45]. Additionally, many signaling pathways have been shown
to participate in manipulating the activity of the NF-kB pathway
[46]. Therefore, the dispensable role of IKKb deletion in
oligodendrocyte viability likely reflects that IKKb deletion alone
does not significantly decrease the activity of the NF-kB pathway
in oligodendrocytes in EAE mice. Clearly, the precise role of the
NF-kB pathway in oligodendrocytes in immune-mediated demy-
elinating diseases warrants further investigation. A transgenic
mouse model that allows for the temporally controlled expression
of IkBaDN, a super-suppressor of NF-kB, exclusively in oligoden-
drocytes could be an ideal model to address this important open
question.
In summary, we have demonstrated that the PERK branch of
the UPR contributes to IFN-c-induced NF-kB activation in
oligodendrocytes. Moreover, our findings indicate that NF-kB
activation is beneficial to oligodendrocytes. As such, this study
reveals a novel mechanism by which IFN-c activates the NF-kB
pathway. Additionally, the results presented in this study suggest
that NF-kB activation by IFN-c represents one mechanism by
which IFN-c exerts its effects on oligodendrocytes in immune-
mediated demyelinating diseases.
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